BAM
SGYP

Bruderman Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bruderman Asset Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,000
Closed – – 728
2018
Q4 		$0 Buy
+2,000
New +$1.31K ﹤0.01% 711

Other funds holding SGYP

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return